ObjectiveTo assess changes in the great saphenous vein (GSV) after foam sclerotherapy
for varicose veins.Materials and MethodsThis was a prospective study of 33 patients who were treated with polidocanol
foam sclerotherapy after having had varicose veins with a clinical
severity-etiology-anatomy-pathophysiology classification of C4-C6 for three
months. The patients were evaluated by ultrasound before, during, and after
the procedure (on post-procedure days 7, 15, 30, 60, and 90). The GSV
diameter, the rate of venous occlusion, and the rate of reflux elimination
were determined. Two patients were excluded for having a history of deep
vein thrombosis history, and one was excluded for having bronchial
asthma.ResultsThirty patients (26 females and 4 males, with mean age of 62 years) completed
the protocol. The mean pre-procedure GSV diameter was 6.0 ± 0.32 mm
(range, 3.6-11.2 mm). During the sclerotherapy, the mean GSV diameter was
reduced to 1.9 ± 0.15 mm (range, 0.6-3.8 mm). On post-procedure day
7, the mean GSV diameter increased to 6.3 ± 0.28 mm (range, 3.9-9.7
mm). On post-procedure day 90, the mean GSV diameter was 4.0 ± 0.22
mm (range, 1.9-8.2 mm). The rate of GSV reflux was significantly lower in
the assessment performed on post-procedure day 90 than in the pre-procedure
assessment (p < 0.0028).ConclusionOn the basis of our ultrasound analysis, we can conclude that foam
sclerotherapy for varicose veins results in a significant reduction in GSV
diameter, as well as in the elimination of GSV reflux.